Uncategorized -
SHANGHAI, China, May 21, 2024 (GLOBE NEWSWIRE) — ECARX Holdings Inc. (Nasdaq: ECX) (“ECARX” or the “Company”), a global mobility […]
Read More
Uncategorized -
GERMANTOWN, Md., May 21, 2024 (GLOBE NEWSWIRE) — Orgenesis Inc. (NASDAQ: ORGS) (“Orgenesis” or the “Company”), a global biotech company […]
Read More
Uncategorized -
MONTVALE, N.J., May 21, 2024 (GLOBE NEWSWIRE) — Balchem Corporation (NASDAQ: BCPC), a global specialty ingredient manufacturer for health and […]
Read More
Uncategorized -
LAVA-1207 dose escalation progressing in Phase 1/2a trial in prostate cancer, with pembrolizumab combination expected to begin in Q2 2024 […]
Read More
Uncategorized -
Translational data presented during a late-breaker poster session from a head-to-head study of eblasakimab and dupilumab in a human tissue […]
Read More
Uncategorized -
BEIJING, May 21, 2024 (GLOBE NEWSWIRE) — KANZHUN LIMITED (“BOSS Zhipin” or the “Company”) (Nasdaq: BZ; HKEX: 2076), a leading […]
Read More
Uncategorized -
MAINZ, Germany, May 21, 2024 – BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) will present clinical trial data for […]
Read More
Uncategorized -
$68.3 million of Net Revenue+21.0% Comparable Net Revenue: +20.6% Obagi Skincare and +21.5% Milk MakeupAdjusted EBITDA of $11.4 million, up […]
Read More
Uncategorized -
Ordinary shares will continue to trade on the Nasdaq Capital Market, and the Company’s listing on such exchange is not […]
Read More
Uncategorized -
SINGAPORE, May 21, 2024 (GLOBE NEWSWIRE) — Sound Group Inc. (“Sound Group” or the “Company”) (NASDAQ: SOGP), formerly known as […]
Read More